These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23372684)

  • 21. Identification and characterization of proliferative retinopathy-related long noncoding RNAs.
    Zhou RM; Wang XQ; Yao J; Shen Y; Chen SN; Yang H; Jiang Q; Yan B
    Biochem Biophys Res Commun; 2015 Sep; 465(3):324-30. PubMed ID: 26241674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Periostin in the Pathogenesis of Proliferative Vitreoretinopathy].
    Ishikawa K
    Nippon Ganka Gakkai Zasshi; 2015 Nov; 119(11):772-80. PubMed ID: 26685481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
    Laudańska-Olszewska I; Omulecki W; Dziegielewski K; Pikulski Z; Omulecka A
    Klin Oczna; 2006; 108(1-3):28-31. PubMed ID: 16883935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Alterations in the structure of the epiretinal membranes in PVR -- assumptions and reality].
    Vidinova C; Voinov L; Vidinov N
    Klin Monbl Augenheilkd; 2005 Jul; 222(7):568-71. PubMed ID: 16034724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy.
    Ioachim E; Stefaniotou M; Gorezis S; Tsanou E; Psilas K; Agnantis NJ
    Eur J Ophthalmol; 2005; 15(3):384-91. PubMed ID: 15945009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apelin in epiretinal membranes of patients with proliferative diabetic retinopathy.
    Lu Q; Ma Y; Xu YS; Jiang YR
    Mol Vis; 2014; 20():1122-31. PubMed ID: 25324682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of wild-type p53-induced phosphatase 1 in diabetic epiretinal membranes.
    Xu J; Zhong H; Cui L; Lan Q; Chen L; He W; Wu Y; Jiang L; Huang H; Zhao X; Li L; Zeng S; Li M; Xu F
    Oncotarget; 2017 May; 8(22):35532-35541. PubMed ID: 28402943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Position of macula lutea and presence of proliferative vitreoretinopathy affect vitreous cytokine expression in rhegmatogenous retinal detachment.
    Balogh A; Milibák T; Szabó V; Nagy ZZ; Resch MD
    PLoS One; 2020; 15(6):e0234525. PubMed ID: 32542038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Barile GR; Chang SS; Park LS; Reppucci VS; Schiff WM; Schmidt AM
    Curr Eye Res; 1999 Sep; 19(3):219-27. PubMed ID: 10487959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of cytokines and trophic factors in epiretinal membranes: involvement of signal transduction in glial cells.
    Harada C; Mitamura Y; Harada T
    Prog Retin Eye Res; 2006 Mar; 25(2):149-64. PubMed ID: 16377232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitreous levels of Lipocalin-2 on patients with primary rhegmatogenous retinal detachment.
    Batsos G; Christodoulou E; Vartholomatos G; Galanis P; Stefaniotou M
    PLoS One; 2019; 14(12):e0227266. PubMed ID: 31891637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trypan blue staining of epiretinal membranes in proliferative vitreoretinopathy.
    Feron EJ; Veckeneer M; Parys-Van Ginderdeuren R; Van Lommel A; Melles GR; Stalmans P
    Arch Ophthalmol; 2002 Feb; 120(2):141-4. PubMed ID: 11831915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localisation of opticin in human proliferative retinal disease.
    Pattwell DM; Sheridan CM; Le Goff M; Bishop PN; Hiscott P
    Exp Eye Res; 2010 Mar; 90(3):461-4. PubMed ID: 20036236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis in proliferative vitreoretinopathy.
    El Ghrably I; Powe DG; Orr G; Fischer D; McIntosh R; Dua HS; Tighe PJ
    Invest Ophthalmol Vis Sci; 2004 May; 45(5):1473-9. PubMed ID: 15111604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Septin expression in proliferative retinal membranes.
    Xin X; Pache M; Zieger B; Bartsch I; Prünte C; Flammer J; Meyer P
    J Histochem Cytochem; 2007 Nov; 55(11):1089-94. PubMed ID: 17625225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment.
    Balogh A; Milibák T; Szabó V; Nagy ZZ; Kaarniranta K; Resch MD
    BMC Ophthalmol; 2020 Dec; 20(1):491. PubMed ID: 33371882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of thrombin in proliferative vitreoretinopathy.
    Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lamellar macular hole: a clinicopathologic correlation of surgically excised epiretinal membranes.
    Parolini B; Schumann RG; Cereda MG; Haritoglou C; Pertile G
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9074-83. PubMed ID: 22025575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Surgically Excised Premacular Membranes in Eyes with Macular Pucker and Proliferative Vitreoretinopathy.
    Guenther SR; Schumann RG; Hagenau F; Wolf A; Priglinger SG; Vogt D
    Curr Eye Res; 2019 Mar; 44(3):341-349. PubMed ID: 30373411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.